5 Authorized Generics Hit Japan Market on June 19

Five of seven authorized first generics that joined the NHI price list on June 19 hit the Japanese pharmacy shelves the same day, including Daiichi Sankyo Espha’s versions of the hyperlipidemia med Zetia (ezetimibe) and Alzheimer’s disease treatment Memary (memantine)...read more